Measuring key aspects of the brain, such as its structure and molecular biology, helps us understand both the hallmarks of the healthy brain and the harbingers of disease. New studies are needed to translate our knowledge of vascular health in other organs, like the heart, and apply it to the brain. We seek funding for new instruments to support this work, including next-generation positron emission tomography (PET) cameras along with a novel device that can stimulate the brain with precision and study how it responds.

With a progressive disease like cancer, every day counts. Treating the patient with an ineffective therapy can have dire consequences, as time wasted allows the disease to progress. Precision imaging helps clinicians better understand each patient’s subtype of disease and choose the most appropriate treatment strategy. We hope to invest in technology and equipment that will expedite clinical trials studying how to predict a patient’s response to certain cancer therapies more accurately.

Image-guided therapy helps clinicians plan, conduct and evaluate surgical procedures and therapeutic interventions. It holds the promise of increasing the precision of personalized treatments and the safety of minimally invasive therapies. We seek to support the development of techniques that will lead to new therapies for complex conditions such as cancer, brain disorders and cardiovascular diseases.

You are using an unsupported browser. Please use the latest version of Chrome, Firefox, Safari or Edge.

Imaging

We’re playing a leading role in the era of image-driven patient care, helping diagnose diseases earlier, monitor treatments more effectively and deliver therapies with greater precision.

Give Now

on this page:

Mass General Imaging hosts the country’s largest hospital-based imaging research program, with approximately $105 million spent annually on related research.

As one of the few academic medical centers where physicians and scientists across multiple disciplines collaborate closely to advance medical imaging, Mass General has been — and will remain — home to many important breakthroughs in the field.
Our multispecialty neuroscience initiative consists of 2,000+ experts who are changing the way patients and caregivers interact, offering an ever-expanding array of brain- and spine-related services.
We are co-founder of the MGH/BWH Center for Clinical Data Science, which is working to combine a wealth of health care data with computational resources to create new ways of solving a variety of health care issues.

Mass General is well-positioned to continue advancing the frontiers of imaging with our …

0 +

clinical and research faculty

0 +

postdoctoral trainees

Imagine a future where ...

Expert faculty use new imaging technologies to predict and measure deterioration in brain health long before clinical symptoms arise.

Investigators harness artificial intelligence (AI) to better understand the processes behind devastating neurological diseases and diagnose these diseases more quickly and accurately.

New therapies integrate advances in high-resolution imaging with increasing precision, leading to minimally invasive interventions that replace many of the aggressive surgical treatments of the past.

With your support, we’ll bring this future to life, enabling patients and caregivers to make informed decisions on appropriate treatment plans with greater confidence.

Featured Story

MRI: Going Mobile for the Masses

When it was first introduced in the late 1970s, magnetic resonance imaging (MRI) was a diagnostic revelation. Forty years later, the technology has evolved considerably. Thanks to the efforts of Mass General imaging physicist Matt Rosen, PhD, low-cost portable MRI devices could soon transform global health care.